Femasys (FEMY) Competitors $0.98 +0.09 (+10.15%) (As of 11/20/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends FEMY vs. POCI, LNSR, VANI, MODD, MGRM, NSPR, ECOR, HYPR, APT, and LUCDShould you be buying Femasys stock or one of its competitors? The main competitors of Femasys include Precision Optics (POCI), LENSAR (LNSR), Vivani Medical (VANI), Modular Medical (MODD), Monogram Orthopaedics (MGRM), InspireMD (NSPR), electroCore (ECOR), Hyperfine (HYPR), Alpha Pro Tech (APT), and Lucid Diagnostics (LUCD). These companies are all part of the "medical equipment" industry. Femasys vs. Precision Optics LENSAR Vivani Medical Modular Medical Monogram Orthopaedics InspireMD electroCore Hyperfine Alpha Pro Tech Lucid Diagnostics Precision Optics (NASDAQ:POCI) and Femasys (NASDAQ:FEMY) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, valuation, institutional ownership, earnings, community ranking, media sentiment, dividends, profitability and analyst recommendations. Which has better earnings and valuation, POCI or FEMY? Precision Optics has higher revenue and earnings than Femasys. Precision Optics is trading at a lower price-to-earnings ratio than Femasys, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPrecision Optics$18.98M1.79-$2.95M-$0.62-8.63Femasys$1.26M17.75-$14.25M-$0.81-1.21 Do analysts prefer POCI or FEMY? Femasys has a consensus price target of $10.00, suggesting a potential upside of 923.54%. Given Femasys' stronger consensus rating and higher possible upside, analysts clearly believe Femasys is more favorable than Precision Optics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Precision Optics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Femasys 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00 Do insiders and institutionals have more ownership in POCI or FEMY? 13.7% of Precision Optics shares are owned by institutional investors. Comparatively, 65.3% of Femasys shares are owned by institutional investors. 16.3% of Precision Optics shares are owned by company insiders. Comparatively, 12.3% of Femasys shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. Does the MarketBeat Community believe in POCI or FEMY? Femasys received 29 more outperform votes than Precision Optics when rated by MarketBeat users. Likewise, 70.73% of users gave Femasys an outperform vote while only 0.00% of users gave Precision Optics an outperform vote. CompanyUnderperformOutperformPrecision OpticsOutperform VotesNo VotesUnderperform Votes2100.00% FemasysOutperform Votes2970.73% Underperform Votes1229.27% Is POCI or FEMY more profitable? Precision Optics has a net margin of -20.01% compared to Femasys' net margin of -1,435.77%. Precision Optics' return on equity of -35.51% beat Femasys' return on equity.Company Net Margins Return on Equity Return on Assets Precision Optics-20.01% -35.51% -21.67% Femasys -1,435.77%-141.49%-82.30% Does the media refer more to POCI or FEMY? In the previous week, Femasys had 3 more articles in the media than Precision Optics. MarketBeat recorded 9 mentions for Femasys and 6 mentions for Precision Optics. Precision Optics' average media sentiment score of 0.29 beat Femasys' score of -0.56 indicating that Precision Optics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Precision Optics 1 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Femasys 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Negative Which has more risk and volatility, POCI or FEMY? Precision Optics has a beta of 0.21, meaning that its stock price is 79% less volatile than the S&P 500. Comparatively, Femasys has a beta of -2.83, meaning that its stock price is 383% less volatile than the S&P 500. SummaryPrecision Optics and Femasys tied by winning 9 of the 18 factors compared between the two stocks. Ad Wyatt Investment ResearchMy #1 Pre IPO Trade for 2025 – NAME and TICKEROne tiny company... Could quickly become "the next SpaceX." It plans to go public on the NASDAQ. And today you can buy Pre-IPO shares for less than $4.00. Get urgent details inside this free report...The Next SpaceX Pre-IPO Get Femasys News Delivered to You Automatically Sign up to receive the latest news and ratings for FEMY and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart FEMY vs. The Competition Export to ExcelMetricFemasysSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$22.37M$4.41B$5.01B$8.81BDividend YieldN/A41.16%5.16%4.06%P/E Ratio-1.2124.82134.3717.77Price / Sales17.7547.021,158.6875.18Price / CashN/A51.8733.5332.53Price / Book1.154.974.674.68Net Income-$14.25M$13.76M$119.07M$226.08M7 Day Performance-0.31%-1.08%-1.83%-1.04%1 Month Performance-24.56%0.58%-3.62%1.04%1 Year Performance8.31%50.91%31.63%26.28% Femasys Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)FEMYFemasys2.4841 of 5 stars$0.98+10.1%$10.00+923.5%+2.8%$22.37M$1.26M-1.2130Analyst RevisionGap UpPOCIPrecision Optics0.8663 of 5 stars$5.35+0.6%N/A-11.1%$33.78M$19.10M0.0080LNSRLENSAR2.1504 of 5 stars$7.28-2.5%$8.00+9.9%+237.0%$86.76M$42.16M0.00110Positive NewsVANIVivani Medical3.1093 of 5 stars$1.29flat$3.00+132.6%+35.6%$76.41MN/A-2.8720MODDModular Medical3.0504 of 5 stars$2.06-1.9%$5.00+142.7%+104.0%$72.60MN/A0.0039Positive NewsMGRMMonogram Orthopaedics1.094 of 5 stars$2.00-2.0%N/A-38.8%$70M$370,000.000.0028NSPRInspireMD2.5564 of 5 stars$2.67+3.9%$4.50+68.5%-4.0%$67.04M$6.20M0.0050Analyst ForecastECORelectroCore0.8003 of 5 stars$9.94-1.5%N/A+62.7%$65.11M$16.03M-5.4350Analyst RevisionHigh Trading VolumeHYPRHyperfine2.7519 of 5 stars$0.90+3.4%$1.43+58.3%-23.1%$63.15M$11.03M0.00190High Trading VolumeAPTAlpha Pro TechN/A$5.29-1.1%N/A+11.1%$58.13M$59.29M14.28120LUCDLucid Diagnostics3.2198 of 5 stars$1.00+4.2%$3.69+268.8%-23.1%$56.72M$2.43M0.0070 Related Companies and Tools Related Companies Precision Optics Alternatives LENSAR Alternatives Vivani Medical Alternatives Modular Medical Alternatives Monogram Orthopaedics Alternatives InspireMD Alternatives electroCore Alternatives Hyperfine Alternatives Alpha Pro Tech Alternatives Lucid Diagnostics Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:FEMY) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Femasys Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Femasys With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
